ロード中...
Advances in targeted therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...
保存先:
| 出版年: | Biomark Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/ https://ncbi.nlm.nih.gov/pubmed/32477567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|